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Abstract
This paper investigates market-consistent valuation of insurance liabilities in the
context of, for instance, Solvency II and to some extent IFRS 4. We propose an explicit
and consistent framework for the valuation of insurance liabilities which incorporates
the Solvency II approach as a special case.
The proposed framework is based on dynamic replication over multiple (one-year)
time periods by a portfolio of assets with reliable market prices, allowing for ”limited
liability” in the sense that the replication can in general not always be continued.
The asset portfolio consist of two parts: (1) assets whose market price defines the
value of the insurance liabilities, and (2) capital funds used to cover risk which cannot
be replicated. The capital funds give rise to capital costs; the main exogenous input
of the framework is the condition on when the investment of the capital funds is
acceptable.
We investigate existence of the value and show that the exact calculation of the
value has to be done recursively backwards in time, starting at the end of the lifetime
of the insurance liabilities. The main question only partially considered in this paper
is the uniqueness of the value. We derive upper bounds on the value and, for the
special case of replication by risk-free one-year zero-coupon bonds, explicit recursive
formulas for calculating the value.
Valuation in Solvency II and IFRS 4 is based on representing the value as a sum of
a ”best estimate” and a ”risk margin”. In our framework, it turns out that this split is
not natural. Nonetheless, we show that a split can be constructed as a simplification,
and that it provides an upper bound on the value under suitable conditions. We
illustrate the general results by explicitly calculating the value for a simple example.
Keywords. Market-consistent valuation of insurance liabilities, technical provisions,
dynamic replication, Solvency II, Swiss Solvency Test, cost of capital, risk margin, best
estimate
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Introduction
Our starting point is market-consistent valuation of insurance liabilities (”technical provi-
sions”) under Solvency II. References to the approach include the Solvency II Framework
Directive, DIRECTIVE 2009/138/EC [?], the draft Level 2 Implementation Measures,
”Rules relating to technical provisions”, EIOPC/SEG/IM13/2010 [?], as well as related
documents such as the CRO Forum position paper [?], the report by the Risk Margin
Working Group [?], and CEIOPS-DOC-36/09 (former CP 42) [?]. Many of the concepts
used by Solvency II had earlier been introduced in the Swiss Solvency Test (SST), see for
instance Federal Office of Private Insurance [?].
In Solvency II, according to Article 77 in DIRECTIVE 2009/138/EC [?], the market-
consistent value of an insurance liability is determined in one of two ways: If the cash-
flows of the liability (or part of the cash-flows) can be replicated reliably using financial
instruments for which a reliable market value is observable, then the value (of the part
of the cash-flows) is determined on the basis of the market value of these instruments.
Otherwise, the value is equal to the sum of best estimate and risk margin,
Market-consistent value = best estimate + risk margin. (1)
In Article 77 of the DIRECTIVE 2009/138/EC [?], the best estimate is defined as the
”probability-weighted average of future cash-flows, taking account of the time value of
money (expected present value of future cash-flows), using the relevant risk-free interest
rate term structure,” and the risk margin is ”calculated by determining the cost of provid-
ing an amount of eligible own funds equal to the Solvency Capital Requirement necessary
to support the insurance and reinsurance obligations over the lifetime thereof.”
In EIOPC/SEG/IM13/2010 [?], the risk margin is expressed by a cost of capital ap-
proach as the sum of the costs of future required capital SCRt by the expression
Risk margin = CoC ·
∑
t≥0
SCRt
(1 + rt+1)t+1
. (2)
where CoC denotes the cost of capital rate, which is assumed deterministic and constant
and, in EIOPC/SEG/IM13/2010 [?], is set to 6% above the risk-free rate. The sum is
over all years t, and rt+1 denotes the risk-free discount rate for t+ 1 years, which means
that the capital costs of year t are discounted back from the end of year t. The infinite
sum above will be finite in practice, limited by the lifetime of the corresponding liabilities.
In the formula (2), SCRt denotes the Solvency Capital Requirement from Solvency II
for the year t, i.e. the required capital, which is defined in Article 101 of DIRECTIVE
2009/138/EC [?] to correspond ”to the Value-at-Risk of the basic own funds of an insur-
ance or reinsurance undertaking subject to a confidence level of 99, 5% over a one-year
period.” We consider SCRt in more detail in Section 2, but note here the following: for
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future years t > 0, SCRt depends on the future state at the beginning of year t, which is
currently not known. Consequently, SCRt for t > 0 is a random variable, implying that
the risk margin as defined by (2) is a random variable and not a number, as it ought to
be.
To avoid this problem, every SCRt in (2) could be replaced with the current expected
value of the random variable SCRt, so that the risk margin would correspond to the
expected costs of future required capital. On might then think that this ”expected risk
margin” is only sufficient in expectation. However, as we show in Section 5, it turns
out that, under suitable assumptions, the ”expected risk margin” is sufficient not just in
expectation but always.
As an additional complication, according to EIOPC/SEG/IM13/2010 [?], the SCRt
used for calculating the risk margin in Solvency II is not calculated for the company (un-
dertaking) under consideration, but for a ”reference undertaking” to which the insurance
liabilities are hypothetically transferred. The features of the transfer and the properties
of the reference undertaking are specified in detail in EIOPC/SEG/IM13/2010 [?].
The preceding comments aim to indicate that valuation of insurance liabilities accord-
ing to Solvency II is not obvious and that a more explicit framework might be needed. The
objective of this paper is to propose such a framework, which incorporates the Solvency
II approach as a special case. The proposed framework expresses the value in terms of
the market price of a portfolio of assets. It is based on dynamic replication over multiple
time periods of the cash-flows of the insurance liabilities by portfolios of assets with reli-
able market prices. In this sense, it relies on the seminal idea of valuation by replication
underlying the (risk-neutral) pricing of financial derivatives.
The framework needs to capture two additional aspects. The first additional aspect is
that insurance liabilities can typically not be perfectly replicated by assets with reliable
market prices, so there remains a part of the cash-flows which cannot be replicated.
According to Solvency II, the non-replicable part of the cash-flows is covered by capital
funds, giving rise to capital costs. The second additional aspect is that the replication
cannot always be continued. In Solvency II, this is because the required capital funds are
given by the Solvency Capital Requirement in terms of the VaR at 99.5%, which implies
that they will be insufficient with 0.5% probability.
The main exogenous assumption in the framework is what we call the ”acceptability
condition” in the remainder of this paper. The acceptability condition is the condition on
when the stochastic return on the capital funds is acceptable to the investor of the capital
funds. In other words, it specifies the ”price” of the capital investment. In this paper,
we work with the acceptability condition implicit in the definition of the risk margin in
Solvency II, which is that the expected excess return over the risk-free return is equal
to the capital cost rate CoC. We note that this acceptability condition is formulated
independently of the capital investor and so does not take into account the specific risk
profile of a given investor.
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In general, the value of the insurance liabilities can depend on the assumptions made
about future new business written, as future new business might diversify with the run-off
of the current business. In this paper, we consider a ”run-off” situation in the sense that
we assume that no future new business is written.
Under the proposed framework, it turns out that a precise calculation of the value
needs to be done recursively backwards in time, starting at the end of the lifetime of the
insurance liabilities. Moreover, we find that there is no natural split of the value into a
”best estimate” and a ”risk margin”; the value is simply given as the market price of a
specific portfolio of assets. However, we show in Section 5 that, under certain conditions,
a split can be introduced, and that the resulting sum of ”best estimate” and ”risk margin”
is not equal to the value but provides an upper bound.
The proposed framework can be situated in the context of (market-consistent) valu-
ation in incomplete markets. At present, on the one hand, there is extensive academic
literature on aspects of valuation by dynamic replication and in incomplete markets, while,
on the other hand, from a practitioner’s perspective, there are numerous articles about
certain aspects of the Solvency II valuation, such as simplified approaches, the risk-free
rate, the cost of capital rate etc. This paper aims to bridge the two areas, by formulating
Solvency II valuation in the framework of dynamical replication in incomplete markets
and in this way defining what it really means.
The recent paper Salzmann-Wu¨thrich [?] provides a discussion of a mathematically
consistent multi-period risk measure approach for the calculation of a risk margin to cover
possible shortfalls in the liability runoff of general (i.e. non-life) insurance companies.
Moreover, explicit calculations are presented by means of a Bayes chain ladder model and
a risk measure chosen to be a multiple of the standard deviation.
Our approach is related to the Valuation Portfolio (VaPo) according to Bu¨hlmann [?]
and Wu¨thrich et al. [?]: An insurance obligation can be better understood not in terms
of monetary values but as a collection of appropriately chosen financial instruments. In
contrast to the VaPo approach, we do not express the actual liability as a portfolio of
potentially synthetic instruments, but consider replication of the liability’s cash-flows by
a portfolio of assets with reliable market prices.
The risk margin in the context of the one-year risk is also investigated in Ohlsson-
Lauzeninsks[?].
We mention here also the classical paper Artzner et al. [?] on coherent risk measures
or, equivalently, ”acceptable future net worths”. While risk measures play a prominent
part in what follows, that paper considers a one-period setting and does not consider
dynamic replication.
An alternative approach to the acceptability condition is given by utility indifference
pricing similar to Møller [?].
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Organization of the paper
The paper is organized as follows: In Section 1, we set up the mathematical notations
and assumptions, including the filtration used to express available information and risk-
free discounting. In Section 2, we investigate the Solvency II approach to valuation and
solvency as a motivation for our formulation, in Section 3, of the proposed framework for
valuation. In Section 4, we then investigate valuation over multiple one-year time periods
in the proposed framework. In Section 5, we consider the risk margin and prove one of the
main results of this paper: under suitable assumptions, the sum of ”best estimate” and
”risk margin” is an upper bound for the value. Finally, in Section 6, we explicitly calculate
the value for a simple example and show that the upper bound sometimes reverses the
”ordering” of the value between different liabilities.
1 Set up and notation
We consider time periods of one year, where year t = 0, 1 . . . refers to the time-period
[t, t+ 1). To be able to describe actions taken at the end of year t, we denote by (t+ 1)−
a point in time just before time t+ 1.
We assume that there exists a filtration (Ft)t expressing the information available
(known) at time t. To specify the filtration, we use the notation identical to Wu¨thrich
et al. [?]. That is, we define a filtered probability space by choosing a probability space
(Ω,F ,P) and an increasing sequence of σ-fields (Ft)t=0,...,n with
{∅,Ω} = F0 ⊆ F1 ⊆ . . . ⊆ Fn
where we assume Fn = F for simplicity. All random variables considered are assumed to
be adapted to the filtration (Ft)t.
Given a set A, we denote its complement by Ac and its characteristic function by
1A. The characteristic function takes the value 1 on A and 0 on A
c. We consider risk
measures ρ, taking a random variable X to a real number ρ{X}. We define losses to be
negative numbers and the risk ρ of a loss to be a positive number. A risk measure ρ is
called translation-invariant (or cash-invariant) if, for any random variable X and any real
number b, ρ{X + b} = ρ{X} − b. It is called monotone if, for any two random variables
with X1 ≤ X2, we have ρ{X2} ≤ ρ{X1}.
The main objective of the paper is the valuation of a given insurance liability L with
stochastic cash-flows (Xt)t corresponding to claims payments, expenses etc., where Xt
denotes the cash-flow in year t. For simplicity, we assume that the cash-flow Xt occurs
and is known at time (t+ 1)−. In terms of the filtered probability space, we assume that
the cash-flows (Xt)t are adapted to the filtration (Ft)t and that Xt is Ft+1-measurable. At
time t, for instance, intuitively speaking, the value of Xt is not known, but the distribution
of Xt is known.
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We assume throughout the paper that market prices of certain financial instruments
are available at future points in time. That is, the information Ft available at time t
includes the market prices of financial instruments at time t. The future market prices of
instruments are given by stochastic models.
A reference market (or replicating market) is defined to be a set of financial instruments
for which reliable market prices are assumed to exist. As an idealization, market prices
of an instrument are reliable if any quantity of the instrument can instantaneously be
traded without affecting the market price. Typically, it is assumed that, if an instrument
is traded in a deep and liquid market, then its (unique and additive) reliable market
price is an emergent property of the corresponding market. An asset portfolio consisting
of instruments from the reference market is called a reference portfolio (or replicating
portfolio).
Deep and liquid (and transparent) markets are defined in the Solvency II context in
EIOPC/SEG/IM13/2010 [?], which also specifies that the model used for the projection
of market parameters (or market prices) needs to ensure that no arbitrage opportunity
exists. In line with this requirement, we assume in the following that the reference market
is arbitrage-free.
We assume that risk-free zero-coupon bonds are part of the reference market, and
do not specify which other instruments might be in the reference market. As mentioned
above, we assume models for the stochastic future market prices for the instruments in
the reference market.
To express risk-free discounting of a cash-flow x occurring at time s discounted to time
t ≤ s, we write
pv(s→t)(x)
which is to be understood as the value at time t of a risk-free zero-coupon bond in the
appropriate currency with face value x maturing at time s. It is in this sense not possible
to risk-free discount stochastic (as opposed to deterministic) cash-flows, because the cash-
flow of a risk-free zero-coupon bond is deterministic.
We define the risk-free terminal value of an amount x invested at time t in a risk-free
zero-coupon bond maturing at time s ≥ t by
tv(t→s)(x).
Let R
(m)
t denote the annual rate for a risk-free zero-coupon bond at time t with a term of
m = 1, 2 . . . years, so R
(m)
t is Ft-measurable, and
pv(t+m→t)(xt+m) = (1 +R
(m)
t )
−m · xt+m. (3)
Consider a risk-free forward contract set up at time t, which specifies that, at time t+ 1,
for a price of Bmt+1(t) fixed at time t, a risk-free zero-coupon bond is purchased with a
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payoff of 1 at time t+ 1 +m. Because of no-arbitrage, we must have that
(1 +R
(1)
t )
−1 · Bmt+1(t) = (1 +R
(m+1)
t )
−m−1. (4)
It is common to identify the forward price with the expectation at time t of the corre-
sponding bond price, i.e.
Bmt+1(t) = E{(1 +R
(m)
t+1)
−m | Ft}.
In general, the price of a forward contract might contain an additional premium for liq-
uidity, so
Bmt+1(t) ≥ E{(1 +R
(m)
t+1)
−m | Ft}. (5)
Equations (5) and (4) imply that
(1 +R
(1)
t )
−1 · E{(1 +R
(m)
t+1)
−m | Ft} ≤ (1 +R
(m+1)
t )
−m−1.
2 Market-consistent valuation in Solvency II
Because we are proposing a framework for valuation which incorporates Solvency II as
a special case, we investigate in the following the Solvency II approach to valuation and
solvency in more detail. The expressions we derive here are used to motivate the definition
of the general framework in Sections 3 and 4.
To begin with, we consider the Solvency Capital Requirement SCRt, which is defined
to correspond ”to the Value-at-Risk of the basic own funds of an insurance or reinsurance
undertaking subject to a confidence level of 99, 5% over a one-year period.” (DIRECTIVE
2009/138/EC [?]).
For the actual balance sheet of the company (or ”undertaking”) under consideration,
for simplicity, we identify in the following basic and eligible own funds (as defined under
Solvency II) with the available capital, denoted by ACt at time t, which is defined as the
difference between the market-consistent value Vt(At) of the assets At and the market-
consistent value Vt(Lt) of the liabilities Lt,
ACt := Vt(At)− Vt(Lt).
SCRt can then be written in terms of the one-year change of the available capital,
SCRt := pv(t+1→t)
(
ρ
{
AC(t+1)− − tv(t→t+1) (ACt) | Ft
})
, (6)
where the risk measure ρ is prescribed to be the Value-at-Risk V aRα at the α = 99.5-
percentile
ρ{Z} := V aRα{−Z}. (7)
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Note that SCRt is calculated based on the information Ft available at time t.
SCRt is the capital requirement under Solvency II in the assessment of the solvency of
a company. Solvency is effectively specified by the condition that, with 99.5% probability,
at the end of year 0 (at time t = 1−), the market-consistent value of the assets exceed the
market-consistent value of the liabilities,
V1(A1−) ≥ V1(L).
which corresponds to the requirement at time t = 0 that the available capital exceed the
required capital,
AC0 ≥ SCR0,
with SCR0 given by (6) for t = 0. In order to assess the solvency condition, we in
particular need to know the value of the insurance liabilities.
Regarding the value of the insurance liabilities, we recall from the introduction that
the risk margin as a component of the value is defined in terms of the Solvency Capital
Requirement SCRt. However, SCRt is not calculated for the company which currently
holds the insurance liabilities, but for a so-called reference undertaking to which the
insurance liabilities L are hypothetically transferred for the purpose of valuation.
The features of this transfer and the properties of the reference undertaking are defined
in EIOPC/SEG/IM13/2010 [?]. After the transfer, the liability side of the balance sheet
of the reference undertaking is assumed to consist of the transferred insurance liabilities.
The assets are assumed to consist of two parts. The first part is a reference portfolio of
assets we denote by RPt, which is used to cover the value of the insurance liabilities. That
is, the value Vt(L) of the insurance liabilities L at time t is given by the market price of
the reference portfolio
Vt(L) = Vt(RPt) (8)
The second part of the assets consists of available capital ACt, assumed invested risk-free,
equal to the Solvency Capital Requirement SCRt needed for the reference undertaking.
Under these specifications, SCRt from (6) can be rewritten as follows. The available
capital AC(t+1)− at the end of year t (before any potential recapitalization) is given by
the year-end value of the assets reduced by the cash-flow Xt in year t and the year-end
value of the insurance liabilities Vt+1(L), i.e.
AC(t+1)− = tv(t→t+1) (SCRt) + Vt+1(RPt)−Xt − Vt+1(L).
Since ACt = SCRt, we get from (6) the following formula for the SCRt for the purpose
of valuation,
SCRt = pv(t+1→t) (ρ {Vt+1(RPt)−Xt − Vt+1(L) | Ft}) . (9)
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It becomes clear from this expression that, in order to calculate the market-consistent
value Vt(L) at time t by (8), which through the risk margin (or through the acceptability
condition (10) below) depends on SCRt, one first needs to calculate the market-consistent
value Vt+1(L) at time t + 1 etc. This implies that a precise calculation of the market-
consistent value has to be recursively backwards in time.
The expression (9) also shows that underlying market-consistent valuation of insurance
liabilities is dynamic replication with a one-year time period. At time t, the portfolio
RPt, which defines the value Vt(L) through (8), is set up to replicate the random variable
Xt+Vt+1(L) at time t+1. In the case of perfect replication, Vt+1(RPt) is always equal to
Xt+Vt+1(L), so that, at time t+1, a new replicating portfolio RPt+1 can be constructed
by a suitable reinvestment of the assets RPt, and no capital funds are needed.
For insurance liabilities, perfect replication is typically not possible. Hence, additional
capital funds are needed for the instances in which Vt+1(RPt) is less than the sum Xt +
Vt+1(L), so capital funds account for the part of the liability which cannot be replicated.
This gives rise to capital requirements SCRt according to (9), which depend on the real-
world probabilities of different amounts of the difference Vt+1(RPt) − Xt − Vt+1(L). In
general, future new business might be written and thus be added to the balance sheet in
the future, and the corresponding cash-flows might diversify with the cash-flows of the
liability L under consideration. Since insurance liabilities typically run-off over several
years, this means that the current value of an insurance liability is potentially affected by
insurance obligations which are added to the balance sheet in the future, i.e. future new
business, at least until the liability is fully run-off.
In Solvency II, the assumptions on future new business in the calculation of the risk
margin are currently not really clear. In this paper, we consider a ”run-off” situation in
the sense that we assume that no future new business is written.
The capital SCRt comes with a cost to make the capital investment acceptable to the
capital provider, which we express through the acceptability condition. The acceptability
condition is encoded in the definition of the risk margin, and requires that the expected
return on the capital SCRt at the end of year t be equal to a cost of capital rate CoC
in excess of the risk-free rate. The value of the capital investment at the end of the
year is determined from the available capital AC(t+1)− , considering that its value is never
negative, since the capital provider has limited liability. Hence, the acceptability condition
for year t can be written as
E
{
max
{
0, AC(t+1)−
}
| Ft
}
= tv(t→t+1) (SCRt) + CoC · SCRt. (10)
The left hand side of equation (10) is the expected value at time (t+1)− of the investment
of the capital funds, and the right hand side is equal to the risk-free return plus the cost
of capital rate on the capital funds SCRt invested at time t. We find in the following
that the acceptability condition determines the reference portfolio RPt or allows to derive
upper bounds.
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3 Framework for the valuation of insurance liabilities
At a conceptual level, the proposed framework for market-consistent valuation of an in-
surance liability L is based on three ideas:
1. Dynamic replication of the liability cash-flows by assets given by financial instru-
ments with reliable market prices.
2. Covering the remaining non-replicable part of the cash-flows by capital funds pro-
vided by an investor.
3. ”Limited liability”, i.e. the liability cash-flows in general do not need to be provided
for every state of the world.
The first idea is analogous to no-arbitrage or risk-neutral pricing of financial instruments
in complete markets. The second idea accounts for the fact that insurance liabilities, in
particular, can usually not be perfectly replicated by instruments with reliable market
prices, and relates to the requirements by the regulatory authorities, for instance in Sol-
vency II, that companies need to hold a required amount of capital. The third idea relates
to the fact that the required regulatory capital typically only needs to be large enough to
ensure that the insurance obligations can be satisfied with high probability. In Solvency
II, for instance, this is expressed by the 99.5% Value-at-Risk over a one-year time period.
Valuing the liability L then means finding a replication procedure, which at a point in
time t consists of a portfolio of assets composed of a reference portfolio RPt and capital
funds Ct. In a static replication procedure, the portfolio RPt is held over the lifetime of the
liability L. In a discrete dynamic replication procedure, RPt is dynamically adjusted, in
our case (at least) over successive one-year time periods, leading to a sequence of reference
portfolios RPt, RPt+1... The capital investment Ct for year t is tied from time t to time
t+1 and is used to cover cash-flow mismatches between L and RPt in year t and to convert
the assets at time t+ 1 to the next reference portfolio RPt+1. At time t+ 1, new capital
funds potentially need to be raised for covering the next time period.
The capital investment is assumed to have the following two properties:
• As an obligation, the capital investment has lowest seniority (i.e. the capital funds
are used for covering all other obligations).
• The capital investment comes with limited liability (i.e. its value is never negative).
The crucial assumption about the capital investment is the acceptability condition: Under
which conditions is the stochastic return from the capital investment acceptable to the
capital provider? The acceptability condition specifies the risk-return preferences of the
capital investor and is the one input to the framework in addition to the current and
future market prices of the financial instruments available for replication.
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If an acceptability condition is specified and the reference portfolio RPt is set up such
that the capital investment Ct fulfils the acceptability condition, then the value of L at
time t is defined as in (8) to be the market price of the reference portfolio RPt,
Vt(L) := Vt(RPt). (11)
The implicit assumption is that required capital funds can always be raised if an acceptable
(stochastic) return can be provided. In general, (11) only holds at the point in time at
which the corresponding reference portfolio is set up and not in between.1 A major
question which we only partially consider in this paper is the uniqueness of the value
defined according to (11).
In view of the third idea underlying the proposed valuation approach, there is the
further complication that we allow for limited liability in the replication procedure by
limiting the required capital Ct. That is, the liability L does not need to be replicated for
every state of the world.
In a dynamic multi-period replication procedure, limited liability potentially applies
both backwards and forward in time. Limited liability applies backwards in time because
at any point in time we do not only reflect the defaults in the current time period, but
additionally the defaults in any future time period.
Limited liability also applies forward in time, in the sense that, at time t, there are
states of the world in which default has already occurred at a prior point in time. If
the liability L is considered to be a contract with a specific company, this means that,
in such a state, the company has defaulted on its obligations prior to t, and so the
obligations towards future cash-flows cannot be fulfilled anymore to the extent required.
We use a different approach, which appears reasonable from the perspective of an insurance
regulator, and consider the value at time t of the liability ”as such”, characterized by future
cash-flows and future limited liability, disregarding the replication history prior to time t.
4 Valuation under the framework
The valuation of the liability L according to (11) is achieved by calculating recursively
backwards in time, starting at the end of the lifetime of the liability. Let T denote the final
year of the lifetime of L, i.e. T is the smallest whole number such that XT+1,XT+2 . . . = 0.
Then,
VT+1(L) = 0.
1Moreover, to specify acceptability of the stochastic future value of the capital investment, we have to
specify at which time the capital amount Ct is determined, as this is the date at which acceptability of
the return to the capital provider is decided. In the following, we assume that Ct is determined at time t
and not before.
11
In the recursion step, we assume that the value Vt+1(L) at time t+ 1 is known and equal
to the market price of a reference portfolio RPt+1,
Vt+1(L) = Vt+1(RPt+1).
We then have to calculate the value Vt(L) at time t as the market price of a suitable
reference portfolio RPt. To this end, define the random variable Yt+1 to be the sum of
the cash-flow Xt in year t and the value Vt+1(L) at the end of the year,
Yt+1 := Xt + Vt+1(L). (12)
In particular, YT+1 = XT .
For the dynamic replication in year t, the random variable Yt+1 needs to be matched
by assets given by a reference portfolio RPt together with capital funds Ct ≥ 0 provided
for one year by a capital investor. The capital funds Ct are assumed to be invested at
time t in a risk-free one-year zero-coupon bond. We allow for the fact that the replication
cannot always be continued past time t+ 1.
To formalize these assumptions, given a reference portfolio RPt and capital funds Ct,
the set At is defined to be the set of states in which the cash-flow Xt can be provided and
the replication can be continued past time t+1 by converting the assets available at time
t+ 1,
Vt+1(RPt) + tv(t→t+1)(Ct)−Xt,
to the new reference portfolio RPt+1. The set At and its probability γt are thus given by
At :=
{
Yt+1 ≤ tv(t→t+1)(Ct) + Vt+1(RPt)
}
, (13)
γt := P{At | Ft} = E{1At | Ft}.
In view of the characteristics of the capital investment outlined in Section 3, the value of
the capital investment at time t+1 is given by the maximum of zero and the value of the
assets left after all other obligations have been considered, so the value C˜t to the capital
provider at time t+ 1 of the capital investment Ct can be written as
C˜t := 1At ·
(
tv(t→t+1)(Ct) + Vt+1(RPt)− Yt+1
)
. (14)
The acceptability condition is specified in the remainder of the paper as prescribed under
Solvency II and, in particular, expressed in terms of the expected value of the capital
investment. Corresponding to (10), the acceptability condition is defined to be the con-
dition that the expected excess return over risk-free of the capital investment be equal to
a given Ft-measurable ”dividend” Dt ≥ 0,
E{C˜t | Ft} − tv(t→t+1)(Ct) = Dt. (15)
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The acceptability condition (15) translates into an equivalent condition on the reference
portfolio: if we insert the expression (14) for C˜t into (15), we get the condition on the
reference portfolio RPt that
E{1At · Vt+1(RPt) | Ft} = E{1At · Yt+1 | Ft}+ (1− γt) · tv(t→t+1)(Ct) +Dt. (16)
Note that condition (16) is complicated in the sense that it depends on RPt, Ct, Dt, and
At, all of which are in general interlinked with each other.
The value Vt(L) can then be defined in the following way: Given Yt+1 defined in
(12), a reference portfolio RPt, capital funds Ct, the set At and a dividend Dt such that
the acceptability condition (15) or equivalently (16) is satisfied, the value Vt(L) of the
insurance liability L at time t is defined to be the market price of the reference portfolio,
Vt(L) := Vt(RPt). (17)
This immediately entails two questions: Does there always exist a solution to (15), i.e.
can a value always be defined by (17)? If so, is such a solution unique, i.e. is the value
defined by (17) unique? We provide partial answers to these questions below, but we do
not investigate the general question of the uniqueness of the value. In particular, note
that the value defined by (17) in general depends on the set At.
In this respect, we stress that we are not suggesting a ”new” definition of the market-
consistent value; all we claim to have done so far is provide a precise and more general
formulation of the valuation approach for insurance liabilities from Solvency II. The Sol-
vency II approach follows from the general framework by the following three assumptions:
1. The capital Ct is given in terms of the reference portfolio RPt by SCRt defined in
(6) (compare with (9)), i.e. for a translation-invariant risk measure ρ,
Ct := pv(t+1→t) (ρ{Vt+1(RPt)− Yt+1 | Ft}) . (18)
2. ρ is given as in (7) by the Value-at-Risk V aR at the 99.5% percentile.
3. Dt is defined as a constant cost of capital rate η > 0 times the capital, i.e.
Dt := η · Ct. (19)
In addition, the current prescriptions from EIOPC/SEG/IM13/2010 [?] suggest that the
reference portfolio RPt should be selected to minimize the capital Ct. This can be thought
of as a requirement to ensure the uniqueness of the value. However, with the Solvency II
selection of ρ as the 99.5% VaR, the capital Ct according to (18), the set At from (13), and
the acceptability condition (16) are not affected by values of the difference Yt+1−Vt+1(RPt)
beyond their 99.5%-quantile, which suggests there might not be uniqueness even if capital
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is minimized. Of course, an immediate way to ensure uniqueness would be to define the
value as the minimum or infimum of the market prices at time t of all reference portfolios
RPt satisfying the acceptability condition (15) for the same Ct and At.
In the following, we first investigate the existence of solutions to condition (15) under
two different approaches. Next, we derive in Lemma 2 an upper bound on solutions of
(15) and thus on the value defined by (17). Finally, we show in Theorem 4 that a unique
solution exists and can be explicitly calculated if we assume that the reference market
consists only of risk-free zero-coupon bonds and that the capital Ct is defined according
to (18).
For the following proposition, we define an eligible dividend as follows:
Definition An Ft-measurable dividend Dt ≥ 0 from (15) is called an eligible dividend if,
given Ft, Dt is a continuous and monotonously increasing function of Ct with Dt = 0 for
Ct = 0.
Clearly, the dividend Dt defined by (19) is eligible.
We now show that solutions to the acceptability condition (15) exist given a suitable
form of the set At or the capital funds Ct.
Proposition 1. Let Dt be an eligible dividend, and let Yt+1 from (12) be given.
(a) Let RP
(0)
t be a reference portfolio and define the set A
(0)
t by
A
(0)
t := {Yt+1 ≤ Vt+1(RP
(0)
t )}.
Then, there exists a capital amount Ct ≥ 0 and a reference portfolio RPt such
that the corresponding set At defined by (13) is equal to A
(0)
t and the acceptability
condition (15) is satisfied.
(b) Let the capital Ct be given as a function of a reference portfolio RPt by (18) for
a translation-invariant risk measure ρ. Given a reference portfolio RP
(0)
t , let the
corresponding capital C
(0)
t be given by (18) and A
(0)
t by (13).
Then, there exists a reference portfolio RPt with the corresponding capital Ct ≥ 0
given by (18) and the set At given by (13) such that At = A
(0)
t and the acceptability
condition (15) is satisfied.
Proof. To prove (a), we split up the portfolio RP
(0)
t into a reference portfolio RPt and
capital funds Ct ≥ 0 by removing from RP
(0)
t a one-year risk-free zero-coupon bond with
value Ct ≥ 0 to be determined (or going short in the bond). Then,
Vt+1(RP
(0)
t ) = Vt+1(RPt) + tv(t→t+1)(Ct), (20)
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and the acceptability condition (16) for RPt and Ct can be written as the condition on
tv(t→t+1)(Ct) +Dt that
tv(t→t+1)(Ct) +Dt = E{1At · (Vt+1(RP
(0)
t )− Yt+1) | Ft} ≥ 0,
because (20) ensures that the set At, if defined by (13) for RPt and Ct, is equal to A
(0)
t , and
the far right inequality above holds by definition of A
(0)
t . If equality holds in the far right
inequality, then the acceptability condition is satisfied for Ct := 0 and RPt := RP
(0)
t .
If not, then the eligibility of the dividend ensures that we find Ct > 0 such that the
acceptability condition holds.
To prove (b), we use a similar approach as for (a), removing a one-year risk-free zero-
coupon bond from RP
(0)
t to get a new portfolio RPt. The corresponding capital Ct given
by (18) then increases by the corresponding amount because of translation-invariance of
the risk measure ρ, so
Vt+1(RPt) + tv(t→t+1)(Ct) = Vt+1(RP
(0)
t ) + tv(t→t+1)(C
(0)
t ),
hence the set At defined by (13) for RPt and Ct is equal to A
(0)
t , and
E{1At · (Vt+1(RP
(0)
t ) + tv(t→t+1)(C
(0)
t )− Yt+1) | Ft}
= γt · tv(t→t+1)(Ct) + E{1At · (Vt+1(RPt)− Yt+1) | Ft},
so using the acceptability condition (16), we get
tv(t→t+1)(Ct) +Dt = E{1At · (Vt+1(RP
(0)
t ) + tv(t→t+1)(C
(0)
t )− Yt+1) | Ft} ≥ 0
by definition of the set A
(0)
t . The argument then proceeds similarly to (a).
Next, we provide an upper bound on any solution of (15).
Lemma 2. Any solution RPt to the acceptability condition (15) and equivalently (16)
satisfies
E{Vt+1(RPt) | Ft} ≤ E{Yt+1 | Ft}+Dt.
Proof. By the definition (13) of At, we have on the complement A
c
t of At,
1Ac
t
· Vt+1(RPt) < 1Ac
t
· Yt+1 − 1Ac
t
· tv(t→t+1)(Ct).
Taking the expected value conditional on Ft of this expression and adding the result to
(16), we get the claimed inequality.
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If we assume in addition that the expected return on RPt over year t is not less than
the risk-free return, then we get from Lemma 2 the recursive upper bound on Vt(L):
Vt(L) = Vt(RPt) ≤ pv(t+1→t) (E{Xt | Ft}+ E{Vt+1(L) | Ft}+Dt) . (21)
Under suitable assumptions, we can derive a closed formula upper bound from this recur-
sive inequality.
Proposition 3. Assume that (5) holds and that, for any t ≤ s− 1,
E {Xs +Ds | Ft+1} and R
(s−t)
t+1 are independent conditional on Ft. (22)
Assume that, for any year t, the expected return on any reference portfolio RPt is larger
than or equal to the risk-free return. Further assume that, for any t, the set At is given
by (13). Then, the value Vt(L) at time t of the liability L is bounded above by
Vt(L) ≤
T∑
s=t
pv(s+1→t) (E {Xs +Ds | Ft}) . (23)
Proof. We proceed by induction backwards in time, starting from t = T . For t = T , the
claim is given by (21), since VT+1(L) = 0. Now assume that (23) holds for t+1, i.e., using
the notation (3),
Vt+1(L) ≤
T∑
s=t+1
(
1 +R
(s−t)
t+1
)−(s−t)
· E {Xs +Ds | Ft+1} . (24)
The recursive upper bound (21) for t can be written
Vt(L) ≤ (1 +R
(1)
t )
−1 · E{Xt +Dt | Ft}+ (1 +R
(1)
t )
−1 · E{Vt+1(L) | Ft}.
Inserting (24) into this inequality, using (22) and applying first (5) and then (4) proves
(23).
If we assume that the reference market consists only of risk-free zero-coupon bonds,
then the acceptability condition (16) on the reference portfolio RPt explicitly determines
the reference portfolio, given Yt+1, Ct and Dt, and provided that γt > 0. In fact,
Vt+1(RPt) = tv(t→t+1)(Vt(RPt)) is then Ft-measurable, so it can be taken out of the
expectation in (16), and we get
γt · tv(t→t+1)(Vt(RPt)) = E{1At · Yt+1}+ (1− γt) · tv(t→t+1)(Ct) +Dt. (25)
This result can be refined for the special case that the capital Ct is defined in line with
Solvency II by (18) to derive an explicit recursive expression for the value of L.
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Theorem 4. Assume that the set At is given by (13) and the capital Ct by (18). Further
assume that the reference market consists only of the risk-free zero-coupon bonds. Then,
the value Vt(L) at time t of the liability L is uniquely determined by the recursive expression
Vt(L) = pv(t+1→t) (E{1At · Yt+1 | Ft}+ (1− γt) · ρ{−Yt+1 | Ft}+Dt) , (26)
where Dt is an eligible dividend from (15). The set At and the capital Ct can be written
as
At = {Yt+1 ≤ ρ{−Yt+1 | Ft}} , (27)
Ct = pv(t+1→t) (ρ{−Yt+1 | Ft})− Vt(L).
Proof. As the risk measure ρ is translation-invariant, the capital from (18) is given by
tv(t→t+1)(Ct) = ρ{−Yt+1 | Ft} − tv(t→t+1)(Vt(L)), (28)
so the set At is given by (27). Inserting (28) into the expression (25) for Vt(RPt) then
proves (26) as, by definition, Vt(L) = Vt(RPt).
Note that it is not obvious how to derive a reasonable closed formula expression from
the recursive expression (26) because of the ρ-term.
A more concise expression for (26) can be given if we define the random variable Zt+1
as the ”cut-off” of Yt+1,
Zt+1 := 1At · Yt+1 + 1Act · ρ{−Yt+1 | Ft}.
Then the recursion (26) can be written
Vt(L) = pv(t+1→t) (E{Zt+1 | Ft}+Dt) .
5 The risk margin
Recall from the introduction (1) the idea of defining the value of an insurance liability
L by the sum of a ”best estimate”, which we interpret (maybe more generally than in
Solvency II) as the market price of a reference portfolio, and a risk margin corresponding
to capital costs. The idea is that the risk margin accounts for the non-hedgeable part of
the cash-flows of the liability L to be valued. However, in the preceding part of the paper,
a split in best estimate and risk margin was never required. Moreover, the definition of
the risk margin is ambiguous in the context of dynamic multi-period replication, because
there are two conflicting intentions: on the one hand, the ”best estimate” is thought to
capture only the contractual cash-flows of the insurance liability and not capital costs.
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On the other hand, the ”best estimate” should capture the hedgeable part over a one-year
time period, which in general partially includes also future capital costs.
We show in the following that it is possible to define a risk margin, and to use it
to derive an upper bound on the value. However, the risk margin we define depends on
certain assumptions, and other definitions of a risk margin would also be possible.
To define the risk margin, the idea is to split the reference portfolio RPt into a refer-
ence portfolio R˜P t, whose market price is the ”best estimate”, and a portfolio we call a
”dividend portfolio” DPt, such that the dividend portfolio accounts for all capital costs,
and its market price corresponds to the risk margin. So RPt consists of the two portfolios
R˜P t and DPt and, since market prices are additive, the value can then be written as
Vt(L) = Vt(RPt) = Vt(R˜P t) + Vt(DPt).
We assume that DPt consists of a risk-free one-year zero-coupon bond (compare to the
formula (2) for the risk margin in Solvency II). Then, Yt+1 from (12) can be written as
Yt+1 = Xt + Vt+1(R˜P t+1) + Vt+1(DPt+1). (29)
For deriving the split, the reference portfolios R˜P t for every year t are determined first;
they account for all future cash-flows (Xs)s≥t of L and disregard limited liability. That
is, they disregard the fact that the replication cannot always be continued. The dividend
portfolios DPt are constructed afterwards.
Define RM t be the ”expected risk margin” at time t,
RM t :=
T∑
s=t
pv(s+1→t) (E {Ds | Ft}) ,
where Ds for s ≥ t are eligible dividends from (15).
We now prove one of our main results, which is that the sum of the market price of
the reference portfolio R˜P t and the ”expected risk margin” RM t is an upper bound for
the value of L, see (32) as well as Corollary 6 below.
Theorem 5. Let the set At on which the replication can be continued be given by (13),
At =
{
Yt+1 ≤ tv(t→t+1)(Ct) + Vt+1(RPt)
}
.
Assume that the reference portfolio RPt consists of a dividend portfolio DPt in the form
of a one-year risk-free zero-coupon bond and a reference portfolio R˜P t, and that the ac-
ceptability condition (15) is satisfied for a given eligible dividend Dt ≥ 0.
(a) Assume that (5) holds, that the portfolio R˜P t satisfies
E{Vt+1(R˜P t) | Ft} ≥ E{Xt + Vt+1(R˜P t+1) | Ft}, (30)
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and that, for any t ≤ s− 1,
E {Ds | Ft+1} and R
(s−t)
t+1 are independent conditional on Ft. (31)
Then, the value at time t of the liability L satisfies
Vt(L) = Vt(R˜P t) + Vt(DPt) with Vt(DPt) ≤ RM t. (32)
(b) Let the capital Ct be given by (18) for a translation-invariant risk measure ρ,
Ct = pv(t+1→t) (ρ{Vt+1(RPt)− Yt+1 | Ft}) .
Then DPt is given by the recursive expression
Vt(DPt) = pv(t+1→t)
(
E{1At · (Yt+1 − Vt+1(R˜P t)) | Ft}
)
+ (33)
+pv(t+1→t)
(
(1− γt) · ρ{Vt+1(R˜P t)− Yt+1 | Ft}+Dt
)
,
where
Ct = pv(t+1→t)
(
ρ{Vt+1(R˜P t)− Yt+1 | Ft}
)
− Vt(DPt), (34)
At =
{
Yt+1 − Vt+1(R˜P t) ≤ ρ{Vt+1(R˜P t)− Yt+1 | Ft}
}
.
Proof. To prove (a), we need to prove (32), i.e. Vt(DPt) ≤ RM t. To this end, we first
derive a recursive expression for Vt(DPt). In fact, from Lemma 2, we have
E {Vt+1(RPt) | Ft} ≤ E {Yt+1 | Ft}+Dt.
Inserting R˜P t, DPt, and Yt+1 from (29) into this inequality and using (30), we get, since
DPt consists of a one-year risk-free zero-coupon bond,
Vt+1(DPt) = E {Vt+1(DPt) | Ft} ≤ E {Vt+1(DPt+1) | Ft}+Dt. (35)
This implies the recursive upper bound on Vt(DPt),
Vt(DPt) ≤ pv(t+1→t) (E {Vt+1(DPt+1) | Ft}+Dt) .
Arguing as in the proof of Proposition 3 and using (31), the upper bound (32) then follows.
To prove (b), the recursive expression (33) follows from the acceptability condition
(16) by similar arguments as Theorem 4, using that Vt+1(DPt) is Ft-measurable and that
ρ is translation-invariant.
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Remark 1. Note that the upper bound Vt(DPt) ≤ RM t from Theorem 5 (a) holds regard-
less of whether equality holds in (30) or not. This means that the upper bound RM t on
the value Vt(DPt) is not affected by the selection of R˜P t subject to (30), although Vt(DPt)
is. In order to obtain the most useful upper bound on the value, one should thus select
R˜P t as that reference portfolio satisfying (30) which minimizes Vt(R˜P t).
Remark 2. The upper bound from Theorem 5 (a) holds in particular if the portfolio R˜P t
is assumed to consist of a one-year risk-free zero-coupon bond and is defined to be the
reference portfolio matching the expected values of the cash-flows (Xs)s≥t of the liability
L to be valued by risk-free zero-coupon bonds, i.e. if the value Vt(R˜P t) is given by
Vt(R˜P t) =
T∑
s=t
pv(s+1→t) (E {Xs | Ft}) .
This is also the reference portfolio which is ”optimal” in the sense of minimizing Vt(R˜P t)
as in Remark 1 and for which equality holds in (30).
If we assume that the dividend Dt is given as in Solvency II by a constant cost of
capital rate applied to the capital, see (19), then we get the following corollary.
Corollary 6. Assume that (5) holds. Assume that the set At on which the replication
can be continued is given by (13),
At =
{
Yt+1 ≤ tv(t→t+1)(Ct) + Vt+1(RPt)
}
,
with the capital Ct given by (18) for a translation-invariant risk measure ρ,
Ct = pv(t+1→t) (ρ{Vt+1(RPt)− Yt+1 | Ft}) .
Assume that the acceptability condition (15) is satisfied for the dividend Dt given by (19),
i.e. Dt = η ·Ct for some η > 0, and that the reference portfolio RPt consists of a dividend
portfolio DPt in the form of a one-year risk-free zero-coupon bond and a reference portfolio
R˜P t satisfying (30),
E{Vt+1(R˜P t) | Ft} ≥ E{Xt + Vt+1(R˜P t+1) | Ft}.
Define
Y˜t+1 := Xt + Vt+1(R˜P t+1), ∆DPt+1 := Vt+1(DPt+1)− E{Vt+1(DPt+1) | Ft},
and assume that, for any t ≤ s− 1,
E
{
ρ{Vs+1(R˜P s)− Y˜s+1 −∆DPs+1 | Fs} | Ft+1
}
(36)
and R
(s−t)
t+1 are independent conditional on Ft.
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Then we have the upper bound
Vt(L) ≤ Vt(R˜P t) + ˜RM t
with the ”adjusted expected risk margin”
˜RM t :=
η
1 + η
·
T∑
s=t
pv(s+1→t)
(
E
{
ρ{Vs+1(R˜P s)− Y˜s+1 −∆DPs+1 | Fs} | Ft
})
. (37)
Proof. We show that Vt(DPt) ≤ ˜RM t for any t. To this end, we note that the assumptions
of Theorem 5 are satisfied, and so we can insert Dt = η · Ct and the expression (34) for
the capital Ct into (35) to get
(1+R
(1)
t +η) ·Vt+1(DPt) ≤ (1+R
(1)
t ) ·E {Vt+1(DPt+1) | Ft}+η ·ρ{Vt+1(R˜P t)−Yt+1 | Ft}.
Using that ρ is translation-invariant and in view of the definitions of Y˜t+1 and ∆DPt+1,
and with the inequality 1 + η ≤ 1 + R
(1)
t + η, we can write this as the recursive upper
bound
Vt+1(DPt) ≤ E {Vt+1(DPt+1) | Ft}+
η
1 + η
· ρ{Vt+1(R˜P t)− Y˜t+1 −∆DPt+1 | Ft}.
Arguing as in the proof of Proposition 3 and using (36), the upper bound then follows.
In practice, it is often assumed as a simplification that ”the risk margin does not
contribute to the one-year volatility”, i.e.
Vt+1(DPt) ≈ Vt+1(DPt+1) +Dt.
This assumption is implicit in the Swiss Solvency Test (SST) and is often assumed in
Solvency II when the Solvency Capital Requirement needs to be calculated. In our case,
we can formulate the corresponding condition as (for some small ε > 0)
∆DPt+1 = Vt+1(DPt+1)− E{Vt+1(DPt+1) | Ft} ≤ ε · ρ{Vt+1(R˜P t)− Y˜t+1 | Ft}.
I.e. the possible increase in the estimate of Vt+1(DPt+1) from time t to t + 1 is small
compared to the ρ-term. If we assume this holds for any t and, in addition, that the risk
measure ρ is monotone, then we get
ρ{Vt+1(R˜P t)− Y˜t+1 −∆DPt+1 | Ft}
≤ ρ{Vt+1(R˜P t)− Y˜t+1 − ε · ρ{Vt+1(R˜P t)− Y˜t+1 | Ft} | Ft}
= (1 + ε) · ρ{Vt+1(R˜P t)− Y˜t+1 | Ft}
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using that ρ is translation-invariant. We then get for the ”adjusted expected risk margin”
˜RM t from (37) the upper bound
˜RM t ≤
η · (1 + ε)
1 + η
·
T∑
s=t
pv(s+1→t)
(
E
{
ρ{Vs+1(R˜P s)−Xs − Vs+1(R˜P s+1) | Fs} | Ft
})
.
This expression for the risk margin appears to be the one implicitly used in most actual
calculations in the context of Solvency II (and the SST), but without the η-term in the
denominator of the fraction above and with ε set equal to zero.
Note that the capital for any year is calculated above in terms of the one-year change
of the ”best estimate”, and not in terms of the one-year change of the difference between
the value of the assets covering the ”best estimate” and the value of the liability.
6 An example for the calculation of the value
We now explicitly calculate the value for a simple example with two liabilities L1 and L2.
The example illustrates the upper bound from Theorem 5 and shows that the ”ordering”
of the value of two liabilities can change: there are instances in which the value of one
liability is larger than the other but the inequality is reversed between the upper bounds.
We note that the example we present is not realistic as we assume that the risk-free
interest rate is zero and that successive cash-flows are independent. However, it may be
surprising that the change of the ”ordering” occurs even under these assumptions.
We assume that only risk-free zero-coupon bonds are eligible for the replication and
that the risk-free interest rate is zero. These two conditions imply that actually only cash
is available. We further assume that the capital Ct is given by (18) with the risk measure
ρ as in (7) given by the Value-at-Risk at a confidence level 0 < α < 1, and that the
dividend Dt is given by (19) with η > 0. Under these assumptions, Theorem 4 implies
that the value Vt(L) of a liability L is given by
Vt(L) =
1
1 + η
(E{1At · Yt+1 | Ft}+ (1 + η − γt) · ρ{−Yt+1 | Ft}) . (38)
The upper bound on the value according to Theorem 5 becomes
V ut (L) :=
T∑
s=t
E{Xs | Ft}+ η ·
T∑
s=t
E{Cs | Ft} (39)
with Cs = ρ{−Ys+1 | Fs} − Vs(L), (40)
where Xt denotes the claims payment of the insurance liability L in year t. Xt is Ft+1-
measurable, and we assume in addition that its distribution conditional on Fs for any
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0 ≤ s < t + 1 is independent of s, i.e. no information about Xt is revealed before time
t+ 1. In particular, the Xt are independent.
We consider the two years t = 0 and t = 1 and assume Xt = 0 for t ≥ 2. We
suppress conditioning on F0 in the notation, and then get from Theorem 4 and the above
assumption on X1 that
E{1A1 · Y2 | F1} = E{1{X1≤ρ{−X1|F1}} ·X1 | F1} = E{1{X1≤ρ{−X1}} ·X1}
ρ{−Y2 | F1} = ρ{−X1}.
Hence the value at time t = 1 from (38) is
V1(L) =
1
1 + η
(
E{1{X1≤ρ{−X1}} ·X1}+ (1 + η − γ1) · ρ{−X1}
)
.
Since V1(L) thus is F0-measurable, and ρ is translation-invariant, we get from this and
(38) for the value at time t = 0 that
V0(L) =
1
1 + η
(
E{1{X0≤ρ{−X0}} ·X0}+ (1 + η − γ0) · ρ{−X0}+ (1 + η) · V1(L)
)
=
1
1 + η
(
E{1{X0≤ρ{−X0}} ·X0}+ E{1{X1≤ρ{−X1}} ·X1}
)
+
1
1 + η
((1 + η − γ0) · ρ{−X0}+ (1 + η − γ1) · ρ{−X1}) .
With ρ given by the Value-at-Risk at confidence level 0 < α < 1, so γt = α, and for a
normally distributed random variable Z with mean µ and standard deviation σ, we have
ρ{−Z} = V aRα(Z) = µ+ σ · qα
E{1{Z≤ρ(−Z)} · Z} = E{Z} − (1− α) · E{Z | Z > ρ(−Z)} =
= µ− (1− α) ·
(
µ+
φ(qα)
1− α
· σ
)
= α · µ− φ(qα) · σ,
where φ denotes the probability density function and qα the α-quantile of the standard
normal distribution.
Assume that Xt for t = 0, 1 are normally distributed with mean µt and standard
deviation σt. Then the above expressions imply that the values at times t = 0, 1 become
V1(L) = µ1 +
σ1
1 + η
· ((1 + η − α) · qα − φ(qα)),
V0(L) = µ0 + µ1 +
σ0 + σ1
1 + η
· ((1 + η − α) · qα − φ(qα)). (41)
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Inserting this into the expression for the capital amounts C0 and C1 from (40), we get
C0 + C1 = ρ{−X0 − V1(L)} − V0(L) + ρ{−X1} − V1(L) = ρ{−X0}+ ρ{−X1} − V0(L)
=
σ0 + σ1
1 + η
· (α · qα + φ(qα)),
hence the upper bound from (39) on the value at t = 0 becomes
V u0 (L) = µ0 + µ1 +
η · (σ0 + σ1)
1 + η
· (α · qα + φ(qα)). (42)
Now consider two different liabilities: for the first liability L(1), we assume as above
that Xt for t = 0, 1 is normally distributed with mean µt > 0 and standard deviation
σt > 0. So the value V0(L
(1)) and the upper bound V u0 (L
(1)) are given as in (41) and (42),
respectively. The second liability L(2) we define by X1 = 0 and X0 normally distributed
with mean µ0+µ1 and standard deviation (σ
2
0+σ
2
1)
1
2 . Its value V0(L
(2)) and upper bound
V u0 (L
(2)) are then given as in (41) and (42), respectively, but with σ0 + σ1 replaced by
(σ20 + σ
2
1)
1
2 . We get:
Proposition 7. Let L(1) and L(2) be defined as above.
(a) The value and upper bounds of the value at time t = 0 satisfy the inequalities
V0(L
(i)) < V u0 (L
(i)) for i = 1, 2, V u0 (L
(2)) < V u0 (L
(1)).
(b) For any η > 0 sufficiently small,
V0(L
(1)) < V0(L
(2)).
Proof. To prove (a), the first statement (as a non-strict inequality) follows from Theo-
rem 5, but we show it here explicitly by observing that the relevant difference, which has
to be shown to be positive, can be written
η · (α · qα + φ(qα))− ((1 + η − α) · qα − φ(qα)) = (1 + η) · f(α),
where f is defined by
f(α) := φ(qα)− (1− α) · qα.
f(α) is strictly positive for any 0 < α < 1. This follows since it clearly holds for α > 0
close to 0, and f is strictly monotonously decreasing as
f ′(α) = −(1− α) · φ(qα)
−1 < 0 for 0 < α < 1
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which follows from
d
dα
qα = φ(qα)
−1,
d
dx
φ(x) = −x · φ(x)
and f(α)→ 0 for α→ 1−. The second statement holds as (σ20 + σ
2
1)
1
2 < σ0 + σ1 and
g(α) := α · qα + φ(qα) > 0 for 0 < α < 1
which can be shown similarly to the statement on f .
(b) follows from (σ20 +σ
2
1)
1
2 < σ0+σ1 and the strict positivity of f shown in the proof
of (a), which implies that, for fixed α, we have for η > 0 sufficiently small,
(1 + η − α) · qα − φ(qα) < 0. (43)
The inequality between the upper bounds from Proposition 7 (a) is not surprising: the
total loss X1+X2 is the same for the two liabilities, but for the first liability L
(1), the total
loss is distributed over two years and so (because no information about X1 is revealed
before time t = 2) does not allow for taking into account diversification between X0 and
X1. The inequality between the values from Proposition 7 (b) goes into the opposite
direction for η small. In fact, it follows from (43) that, the smaller the safety level α, i.e.
the larger the probability that ”limited liability” applies, the larger the cost of capital
rate η can be such that the inequality still holds.
Conclusions
We have presented a proposal for a framework for market-consistent valuation of insurance
liabilities which incorporates the Solvency II approach as a special case. We have shown
that a value exists under certain conditions, derived upper bounds on such values, and
shown that there exist a unique value defined by an explicit recursive expression if we
restrict replication to risk-free zero-coupon bonds. The question remains open whether
the value is unique in the general case.
Further, we have shown that the representation of the value as a sum of best estimate
and risk margin is a simplification, which under certain conditions provides an upper
bound on the value. By an explicit example, we have calculated the value as well as the
upper bound, and have shown that the expression for the upper bound does not always
preserve the order of the value.
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